0001744333-21-000003.txt : 20210218 0001744333-21-000003.hdr.sgml : 20210218 20210217192904 ACCESSION NUMBER: 0001744333-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210217 EFFECTIVENESS DATE: 20210218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELIXIRGEN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001744333 IRS NUMBER: 830534578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389761 FILM NUMBER: 21646997 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 443-869-5420 MAIL ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001744333 ELIXIRGEN THERAPEUTICS, INC. 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 (443)869-5420 DELAWARE Elixirgen Therapeutics, LLC None Corporation true 2017 Akihiro Ko 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Executive Officer Director Minoru Ko 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Hiroaki Kobayashi 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Naonori Kurokawa 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Thomas White 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Shauna Callahan 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Biotechnology Decline to Disclose 06b false 2021-02-02 false true false 0 5499971 4199985 1299986 false 2 0 0 0 false ELIXIRGEN THERAPEUTICS, INC. Akihiro Ko Akihiro Ko CEO / Director 2021-02-17